Germany’s federal government has formally included alternative proteins in its High-Tech Agenda, with a biotechnology roadmap released by the Federal Ministry of Research, Technology, and Space setting out concrete milestones for cultivated foods and precision fermentation through to 2032.
The roadmap calls for the establishment of a national innovation hub for cell cultivation and precision fermentation by 2027, intended to consolidate research activities that have until now been spread across institutions, reduce duplication, and speed up commercialisation. The government also set a target of bringing biotechnologically produced food products to world markets by 2028.
Ivo Rzegotta, GFI Europe’s lead for Germany, Austria, and Switzerland, said: “The inclusion of cultivated meat and precision fermentation in the high-tech agenda is a first crucial step towards implementing the coalition agreement’s plan to advance sustainable alternative proteins.”
Germany’s funding gap
The announcement has been welcomed by the Good Food Institute Europe (GFI Europe), though the organisation noted that Germany’s public investment in the sector has lagged behind several European peers. According to a GFI Europe analysis published alongside the roadmap, Germany invested €79 million in alternative protein research and innovation between 2020 and 2025, less than €1 per capita, placing it behind the United Kingdom, the Netherlands, and a number of Scandinavian countries.
The analysis also found that roughly four-fifths of German public funding in the space has gone to plant-based proteins, with only around one-fifth directed toward biotechnologically produced foods such as cultivated meat or precision fermentation ingredients.
Despite this, Germany ranks first in Europe for scientific publications in the field and fourth for patents, suggesting a strong research base that has not yet translated into equivalent public investment.
Economic case for the hub
GFI Europe pointed to the UK and Sweden as existing examples, where publicly funded hubs have brought together research institutions, industry partners, and policymakers around openly accessible research. The UK has funded several such centres with grants of €10 to 15 million each.
The roadmap also addresses regulatory barriers, calling for efficient implementation of the EU Novel Food Regulation and for the EU Biotech Act to include provision for regulatory sandboxes covering novel foods, including cultivated meat and precision fermentation products.
Rzegotta continued, “To support the impact of this plan on Germany’s innovation power and technological sovereignty, it is now crucial that the announced innovation hub is secured with sufficient funding and that it is designed in an interdisciplinary manner with industry participation. It is encouraging that the roadmap highlights the role of efficient and transparent approval processes and calls for the EU Biotech Act to include the possibility of establishing regulatory sandboxes for novel foods.”
